| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.32e-05 | 188 | 61 | 6 | GO:0005201 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 1.28e-05 | 16 | 60 | 3 | GO:1901526 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 2.19e-05 | 19 | 60 | 3 | GO:1903599 | |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 4.53e-05 | 24 | 60 | 3 | GO:0030277 | |
| GeneOntologyCellularComponent | mucus layer | 2.35e-05 | 3 | 59 | 2 | GO:0070701 | |
| Domain | TIL_dom | 1.12e-05 | 14 | 60 | 3 | IPR002919 | |
| Domain | VWD | 1.71e-05 | 16 | 60 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.71e-05 | 16 | 60 | 3 | IPR001846 | |
| Domain | VWFD | 1.71e-05 | 16 | 60 | 3 | PS51233 | |
| Domain | VWD | 1.71e-05 | 16 | 60 | 3 | PF00094 | |
| Domain | CTCK_1 | 2.49e-05 | 18 | 60 | 3 | PS01185 | |
| Domain | K_chnl_volt-dep_ERG | 3.04e-05 | 3 | 60 | 2 | IPR003967 | |
| Domain | CT | 4.65e-05 | 22 | 60 | 3 | SM00041 | |
| Domain | G8 | 6.06e-05 | 4 | 60 | 2 | PF10162 | |
| Domain | G8_domain | 6.06e-05 | 4 | 60 | 2 | IPR019316 | |
| Domain | G8 | 6.06e-05 | 4 | 60 | 2 | PS51484 | |
| Domain | G8 | 6.06e-05 | 4 | 60 | 2 | SM01225 | |
| Domain | PAS-assoc_C | 6.08e-05 | 24 | 60 | 3 | IPR000700 | |
| Domain | Cys_knot_C | 6.89e-05 | 25 | 60 | 3 | IPR006207 | |
| Domain | CTCK_2 | 6.89e-05 | 25 | 60 | 3 | PS01225 | |
| Domain | cEGF | 7.77e-05 | 26 | 60 | 3 | IPR026823 | |
| Domain | PAC | 7.77e-05 | 26 | 60 | 3 | IPR001610 | |
| Domain | cEGF | 7.77e-05 | 26 | 60 | 3 | PF12662 | |
| Domain | PAC | 7.77e-05 | 26 | 60 | 3 | SM00086 | |
| Domain | PAC | 7.77e-05 | 26 | 60 | 3 | PS50113 | |
| Domain | EGF_3 | 1.06e-04 | 235 | 60 | 6 | PS50026 | |
| Domain | EGF-like_dom | 1.45e-04 | 249 | 60 | 6 | IPR000742 | |
| Domain | PAS | 1.46e-04 | 32 | 60 | 3 | SM00091 | |
| Domain | PbH1 | 1.51e-04 | 6 | 60 | 2 | SM00710 | |
| Domain | WxxW_domain | 1.51e-04 | 6 | 60 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.51e-04 | 6 | 60 | 2 | PF13330 | |
| Domain | PbH1 | 1.51e-04 | 6 | 60 | 2 | IPR006626 | |
| Domain | EGF_1 | 1.65e-04 | 255 | 60 | 6 | PS00022 | |
| Domain | PAS | 1.76e-04 | 34 | 60 | 3 | IPR000014 | |
| Domain | PAS | 1.76e-04 | 34 | 60 | 3 | PS50112 | |
| Domain | EGF-like_CS | 1.87e-04 | 261 | 60 | 6 | IPR013032 | |
| Domain | EGF_2 | 2.03e-04 | 265 | 60 | 6 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 2.67e-04 | 97 | 60 | 4 | IPR018097 | |
| Domain | Pectin_lyase_fold/virulence | 2.81e-04 | 8 | 60 | 2 | IPR011050 | |
| Domain | EGF_CA | 2.88e-04 | 99 | 60 | 4 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.74e-04 | 106 | 60 | 4 | IPR000152 | |
| Domain | PAS_9 | 4.49e-04 | 10 | 60 | 2 | PF13426 | |
| Domain | EGF_CA | 6.37e-04 | 122 | 60 | 4 | SM00179 | |
| Domain | TIL | 6.56e-04 | 12 | 60 | 2 | PF01826 | |
| Domain | C8 | 6.56e-04 | 12 | 60 | 2 | PF08742 | |
| Domain | EGF-like_Ca-bd_dom | 6.77e-04 | 124 | 60 | 4 | IPR001881 | |
| Domain | EGF | 7.19e-04 | 126 | 60 | 4 | PF00008 | |
| Domain | Unchr_dom_Cys-rich | 7.74e-04 | 13 | 60 | 2 | IPR014853 | |
| Domain | C8 | 7.74e-04 | 13 | 60 | 2 | SM00832 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 9.01e-04 | 14 | 60 | 2 | IPR003938 | |
| Domain | Ldl_recept_b | 9.01e-04 | 14 | 60 | 2 | PF00058 | |
| Domain | LDLRB | 9.01e-04 | 14 | 60 | 2 | PS51120 | |
| Domain | EGF | 9.40e-04 | 235 | 60 | 5 | SM00181 | |
| Domain | EGF_extracell | 9.47e-04 | 60 | 60 | 3 | IPR013111 | |
| Domain | EGF_2 | 9.47e-04 | 60 | 60 | 3 | PF07974 | |
| Domain | LY | 1.04e-03 | 15 | 60 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.04e-03 | 15 | 60 | 2 | IPR000033 | |
| Domain | Disintegrin_CS | 1.18e-03 | 16 | 60 | 2 | IPR018358 | |
| Domain | ADAM_CR | 1.50e-03 | 18 | 60 | 2 | PF08516 | |
| Domain | Growth_fac_rcpt_ | 1.59e-03 | 156 | 60 | 4 | IPR009030 | |
| Domain | VWC_out | 1.68e-03 | 19 | 60 | 2 | SM00215 | |
| Domain | - | 1.86e-03 | 20 | 60 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 2.05e-03 | 21 | 60 | 2 | PF00200 | |
| Domain | DISIN | 2.05e-03 | 21 | 60 | 2 | SM00050 | |
| Domain | PAS_fold_3 | 2.46e-03 | 23 | 60 | 2 | IPR013655 | |
| Domain | PAS_3 | 2.46e-03 | 23 | 60 | 2 | PF08447 | |
| Domain | EGF_CA | 2.67e-03 | 86 | 60 | 3 | PF07645 | |
| Domain | PAS | 2.90e-03 | 25 | 60 | 2 | PF00989 | |
| Domain | PAS_fold | 2.90e-03 | 25 | 60 | 2 | IPR013767 | |
| Domain | HECT | 3.38e-03 | 27 | 60 | 2 | PF00632 | |
| Domain | HECTc | 3.38e-03 | 27 | 60 | 2 | SM00119 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.15e-05 | 21 | 46 | 3 | MM15706 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 23464473 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 5.12e-08 | 5 | 61 | 3 | 11062147 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 5.12e-08 | 5 | 61 | 3 | 16475027 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 17058067 | ||
| Pubmed | The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence. | 5.12e-08 | 5 | 61 | 3 | 20048263 | |
| Pubmed | Arf4 is required for Mammalian development but dispensable for ciliary assembly. | 1.79e-07 | 7 | 61 | 3 | 24586199 | |
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 3.03e-06 | 2 | 61 | 2 | 18475301 | |
| Pubmed | IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma. | 3.03e-06 | 2 | 61 | 2 | 29031476 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17321686 | ||
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 3.03e-06 | 2 | 61 | 2 | 20731025 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23832517 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23832516 | ||
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 3.03e-06 | 2 | 61 | 2 | 19158956 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17203232 | ||
| Pubmed | Hypoxia induces mucin expression and secretion in human bronchial epithelial cells. | 3.03e-06 | 2 | 61 | 2 | 23084780 | |
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 3.03e-06 | 2 | 61 | 2 | 12527922 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19359372 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24840724 | ||
| Pubmed | The nuclear kinesin KIF18B promotes 53BP1-mediated DNA double-strand break repair. | 3.03e-06 | 2 | 61 | 2 | 34192545 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21544845 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11445551 | ||
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 3.03e-06 | 2 | 61 | 2 | 14594655 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12820724 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.11e-06 | 18 | 61 | 3 | 18834073 | |
| Pubmed | Detection of genes regulated by Lmx1b during limb dorsalization. | 8.87e-06 | 23 | 61 | 3 | 22417325 | |
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 9.07e-06 | 3 | 61 | 2 | 23305535 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 24714692 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15961404 | ||
| Pubmed | Differences in the expression of mucins in various forms of cystitis glandularis. | 9.07e-06 | 3 | 61 | 2 | 17659847 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18825309 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18300795 | ||
| Pubmed | Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. | 9.07e-06 | 3 | 61 | 2 | 17333267 | |
| Pubmed | HERG K(+) currents in human prolactin-secreting adenoma cells. | 9.07e-06 | 3 | 61 | 2 | 12634931 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 19718741 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14643686 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 27001172 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 20065027 | ||
| Pubmed | Potassium Ion Channel Protein (KCNH) Levels in Patients with Fibromyalgia Syndrome. | 9.07e-06 | 3 | 61 | 2 | 35818223 | |
| Pubmed | Gene expression profiling of colorectal mucinous adenocarcinomas. | 9.07e-06 | 3 | 61 | 2 | 20485009 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 37967555 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 24920497 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 31128106 | ||
| Pubmed | Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M. | 1.81e-05 | 4 | 61 | 2 | 31249305 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 1.81e-05 | 4 | 61 | 2 | 22269464 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 22691042 | ||
| Pubmed | Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. | 1.81e-05 | 4 | 61 | 2 | 37156999 | |
| Pubmed | Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. | 1.81e-05 | 4 | 61 | 2 | 12391274 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 23807779 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 21647207 | ||
| Pubmed | FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation. | 1.81e-05 | 4 | 61 | 2 | 15574124 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 33154304 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 1.81e-05 | 4 | 61 | 2 | 24901817 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 16198295 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 36367122 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 17471237 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 14984930 | ||
| Pubmed | HIF-1α, NOTCH1, ADAM12, and HB-EGF are overexpressed in mucoepidermoid carcinoma. | 1.81e-05 | 4 | 61 | 2 | 30415904 | |
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.81e-05 | 4 | 61 | 2 | 29869461 | |
| Pubmed | [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. | 1.81e-05 | 4 | 61 | 2 | 17991319 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 1.81e-05 | 4 | 61 | 2 | 20929551 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 1.81e-05 | 4 | 61 | 2 | 27298226 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 23619266 | ||
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 1.81e-05 | 4 | 61 | 2 | 18198997 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 1.81e-05 | 4 | 61 | 2 | 17401217 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 12676567 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 25298197 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LMX1B MYO9B KCNH2 UBE3B KAT6A AMBRA1 BTAF1 HERC1 ARHGEF11 NOD2 | 2.08e-05 | 1105 | 61 | 10 | 35748872 |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 17283184 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 12507512 | ||
| Pubmed | Association between genetic variants in myosin IXB and Crohn's disease. | 3.02e-05 | 5 | 61 | 2 | 19235913 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 12135769 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 3.02e-05 | 5 | 61 | 2 | 16188033 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 18035521 | ||
| Pubmed | Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. | 3.02e-05 | 5 | 61 | 2 | 11580864 | |
| Pubmed | pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. | 3.02e-05 | 5 | 61 | 2 | 10611155 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 22261707 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 19110483 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 16142311 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 17982272 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 20024904 | ||
| Pubmed | The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression. | 4.52e-05 | 6 | 61 | 2 | 17024177 | |
| Pubmed | FOXL2 and BMP2 act cooperatively to regulate follistatin gene expression during ovarian development. | 4.52e-05 | 6 | 61 | 2 | 21084449 | |
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 25537494 | ||
| Pubmed | 6.04e-05 | 120 | 61 | 4 | 27320910 | ||
| Pubmed | Glucose metabolism induced by Bmp signaling is essential for murine skeletal development. | 8.42e-05 | 8 | 61 | 2 | 30446646 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 9.29e-05 | 608 | 61 | 7 | 36089195 | |
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 20860622 | ||
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 1.35e-04 | 10 | 61 | 2 | 26503718 | |
| Pubmed | 1.35e-04 | 1116 | 61 | 9 | 31753913 | ||
| Pubmed | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. | 1.48e-04 | 58 | 61 | 3 | 20935630 | |
| Pubmed | 1.55e-04 | 153 | 61 | 4 | 25037231 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 19416849 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 24639464 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 15913604 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 18804983 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 11714671 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 28700933 | ||
| Pubmed | 2.25e-04 | 313 | 61 | 5 | 20800603 | ||
| Pubmed | Conditional stabilization of beta-catenin expands the pool of lung stem cells. | 2.33e-04 | 13 | 61 | 2 | 18356571 | |
| Cytoband | 2q21.2 | 1.56e-04 | 14 | 61 | 2 | 2q21.2 | |
| GeneFamily | CD molecules|Mucins | 1.73e-05 | 21 | 44 | 3 | 648 | |
| GeneFamily | Low density lipoprotein receptors | 4.44e-04 | 13 | 44 | 2 | 634 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.61e-03 | 718 | 44 | 7 | 28 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.95e-03 | 27 | 44 | 2 | 47 | |
| GeneFamily | Potassium voltage-gated channels | 4.26e-03 | 40 | 44 | 2 | 274 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RLF BMPR1A HIF1A MYO9B KAT6A USP12 ITGA6 BTAF1 OSMR CAMSAP2 ZMYM4 TP53BP1 | 5.45e-07 | 856 | 61 | 12 | M4500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.61e-06 | 233 | 61 | 7 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.69e-06 | 168 | 61 | 6 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.25e-05 | 179 | 61 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-07 | 174 | 61 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-06 | 168 | 61 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.56e-06 | 178 | 61 | 5 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-06 | 178 | 61 | 5 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-06 | 178 | 61 | 5 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 178 | 61 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.35e-06 | 184 | 61 | 5 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.50e-06 | 185 | 61 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-06 | 187 | 61 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-06 | 187 | 61 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-06 | 187 | 61 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.10e-06 | 189 | 61 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-06 | 191 | 61 | 5 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-06 | 191 | 61 | 5 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.46e-06 | 197 | 61 | 5 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.46e-06 | 197 | 61 | 5 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.46e-06 | 197 | 61 | 5 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-06 | 200 | 61 | 5 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.02e-06 | 200 | 61 | 5 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-06 | 200 | 61 | 5 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.21e-05 | 149 | 61 | 4 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.77e-05 | 153 | 61 | 4 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 158 | 61 | 4 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 158 | 61 | 4 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 158 | 61 | 4 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.70e-05 | 159 | 61 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 160 | 61 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 160 | 61 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 161 | 61 | 4 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 161 | 61 | 4 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.20e-05 | 162 | 61 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.55e-05 | 164 | 61 | 4 | 3c15e9b8403b03d67f6ecd7861dc19f1261e3244 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.73e-05 | 165 | 61 | 4 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 7.92e-05 | 166 | 61 | 4 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.92e-05 | 166 | 61 | 4 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.92e-05 | 166 | 61 | 4 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 7.92e-05 | 166 | 61 | 4 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 167 | 61 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 167 | 61 | 4 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 167 | 61 | 4 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 167 | 61 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 169 | 61 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 171 | 61 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 171 | 61 | 4 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 9.08e-05 | 172 | 61 | 4 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.08e-05 | 172 | 61 | 4 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 9.08e-05 | 172 | 61 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-05 | 173 | 61 | 4 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.29e-05 | 173 | 61 | 4 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-05 | 173 | 61 | 4 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-05 | 173 | 61 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.29e-05 | 173 | 61 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-05 | 174 | 61 | 4 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 9.92e-05 | 176 | 61 | 4 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 177 | 61 | 4 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 177 | 61 | 4 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 177 | 61 | 4 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 178 | 61 | 4 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 178 | 61 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 179 | 61 | 4 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 179 | 61 | 4 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 179 | 61 | 4 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 1.08e-04 | 180 | 61 | 4 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-04 | 180 | 61 | 4 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 181 | 61 | 4 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-04 | 181 | 61 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-04 | 181 | 61 | 4 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 181 | 61 | 4 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 183 | 61 | 4 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.15e-04 | 183 | 61 | 4 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 183 | 61 | 4 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 183 | 61 | 4 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 184 | 61 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 184 | 61 | 4 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 184 | 61 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 184 | 61 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.20e-04 | 185 | 61 | 4 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 61 | 4 | 13056622d9921ee0b03325701d94df82ffbaa5d4 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 187 | 61 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.28e-04 | 188 | 61 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.28e-04 | 188 | 61 | 4 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 61 | 4 | 258ef4a52f90236dbed92f325ca033c8fa6156a5 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.31e-04 | 189 | 61 | 4 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 190 | 61 | 4 | 990ac07f4b0a22041daac7502f74fafd6d258cba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 190 | 61 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 190 | 61 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 190 | 61 | 4 | fc9bbe5e6e0ec3cfa47bf479d8b09a0fc53169cc | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 190 | 61 | 4 | 39ecdf8815e235771132684dfc1aff1917e20965 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 191 | 61 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 191 | 61 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 192 | 61 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 192 | 61 | 4 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 192 | 61 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 192 | 61 | 4 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 192 | 61 | 4 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 192 | 61 | 4 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 192 | 61 | 4 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-04 | 193 | 61 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 9.27e-07 | 196 | 61 | 7 | 2221_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.37e-05 | 195 | 61 | 6 | 6039_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.41e-05 | 196 | 61 | 6 | 7182_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.45e-05 | 197 | 61 | 6 | 2635_DN | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 3839_UP | |
| Drug | Ovalbumin | 6.98e-05 | 82 | 61 | 4 | ctd:D010047 | |
| Drug | Doxazosin | 1.05e-04 | 6 | 61 | 2 | DB00590 | |
| Drug | Prazosin | 1.05e-04 | 6 | 61 | 2 | DB00457 | |
| Drug | Terazosin | 1.05e-04 | 6 | 61 | 2 | DB01162 | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.60e-04 | 191 | 61 | 5 | 7195_UP | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 192 | 61 | 5 | 6207_DN | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 4709_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 2295_DN | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 2789_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 7494_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 7538_DN | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A | 1.77e-04 | 195 | 61 | 5 | 4647_UP | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 1.77e-04 | 195 | 61 | 5 | 5245_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.77e-04 | 195 | 61 | 5 | 2649_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 5519_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 4347_DN | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 3563_UP | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 5734_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 7357_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 2811_DN | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 4407_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 3617_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 3176_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 2494_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 6813_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 6204_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 6443_DN | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 7180_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 4658_UP | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 6091_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 2436_UP | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 4717_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 6241_DN | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 7257_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 6447_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 3344_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 5079_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 6950_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 6968_DN | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 6012_UP | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 3560_UP | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 1.96e-04 | 8 | 61 | 2 | ctd:C064545 | |
| Drug | Miconazole | 1.96e-04 | 8 | 61 | 2 | DB01110 | |
| Drug | chlorpropamide; Down 200; 100uM; MCF7; HG-U133A | 1.99e-04 | 200 | 61 | 5 | 141_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.99e-04 | 200 | 61 | 5 | 6450_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.99e-04 | 200 | 61 | 5 | 4787_UP | |
| Drug | linopirdine | 2.09e-04 | 43 | 61 | 3 | CID000003932 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 7.57e-08 | 5 | 59 | 3 | DOID:3030 (is_marker_for) | |
| Disease | cystitis (is_marker_for) | 3.93e-06 | 2 | 59 | 2 | DOID:1679 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 1.18e-05 | 3 | 59 | 2 | OBA_2050332 | |
| Disease | intestinal disease (is_implicated_in) | 1.18e-05 | 3 | 59 | 2 | DOID:5295 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.90e-05 | 163 | 59 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | mucositis (biomarker_via_orthology) | 3.92e-05 | 5 | 59 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 3.97e-05 | 33 | 59 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Schizophrenia | 6.07e-05 | 883 | 59 | 9 | C0036341 | |
| Disease | fat body mass | 7.45e-05 | 217 | 59 | 5 | EFO_0005409 | |
| Disease | Stage IV Skin Melanoma | 8.20e-05 | 7 | 59 | 2 | C1321872 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 8.20e-05 | 7 | 59 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 1.09e-04 | 8 | 59 | 2 | DOID:4608 (is_marker_for) | |
| Disease | health-related quality of life measurement | 1.40e-04 | 9 | 59 | 2 | EFO_0011014 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.40e-04 | 9 | 59 | 2 | EFO_0009824 | |
| Disease | Focal segmental glomerulosclerosis | 1.75e-04 | 10 | 59 | 2 | cv:C0017668 | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.75e-04 | 10 | 59 | 2 | cv:CN327126 | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.75e-04 | 10 | 59 | 2 | DOID:11204 (is_marker_for) | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.75e-04 | 10 | 59 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 2.14e-04 | 11 | 59 | 2 | cv:CN043612 | |
| Disease | endometrial neoplasm | 2.14e-04 | 11 | 59 | 2 | EFO_0004230 | |
| Disease | follistatin measurement | 2.14e-04 | 11 | 59 | 2 | EFO_0010614 | |
| Disease | Abruptio Placentae | 2.56e-04 | 12 | 59 | 2 | EFO_1001754 | |
| Disease | glaucoma | 2.60e-04 | 154 | 59 | 4 | MONDO_0005041 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.73e-04 | 156 | 59 | 4 | C0007131 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.90e-04 | 64 | 59 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 3.02e-04 | 13 | 59 | 2 | cv:C4273714 | |
| Disease | keratoconus | 3.18e-04 | 66 | 59 | 3 | MONDO_0015486 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 3.52e-04 | 14 | 59 | 2 | EFO_0020941 | |
| Disease | susceptibility to childhood ear infection measurement | 3.87e-04 | 171 | 59 | 4 | EFO_0007904 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 4.81e-04 | 76 | 59 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Eye Abnormalities | 5.24e-04 | 17 | 59 | 2 | C0015393 | |
| Disease | otitis media (biomarker_via_orthology) | 5.24e-04 | 17 | 59 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 5.89e-04 | 18 | 59 | 2 | HP_0002373 | |
| Disease | FEV/FEC ratio | 7.01e-04 | 1228 | 59 | 9 | EFO_0004713 | |
| Disease | influenza A (H1N1) | 7.14e-04 | 87 | 59 | 3 | EFO_1001488 | |
| Disease | S-warfarin measurement | 9.80e-04 | 97 | 59 | 3 | EFO_0803323 | |
| Disease | ocular sarcoidosis | 1.64e-03 | 116 | 59 | 3 | EFO_0010723 | |
| Disease | sleep quality | 1.72e-03 | 118 | 59 | 3 | EFO_0005272 | |
| Disease | body surface area | 1.77e-03 | 643 | 59 | 6 | EFO_0022196 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.88e-03 | 32 | 59 | 2 | DOID:10273 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVYISTNCPSQCNEN | 626 | Q9H2U9 | |
| QQVAAQFCSYQSIAL | 826 | O15085 | |
| CYNGICQTHEQQCVT | 521 | O43184 | |
| SESCQQERSCQYLQV | 306 | O14490 | |
| CRTAQIVTQYCVGAN | 216 | P48546 | |
| TDVQLVTQQVIQCAY | 726 | Q14161 | |
| NVLVQNCKIYNDASC | 881 | Q9C0C7 | |
| ISSNYCNCSSIQCNV | 346 | Q09MP3 | |
| ICYVSRNIQNNVSCY | 166 | Q99650 | |
| ILDQCYNFVCVNVTT | 331 | A4D126 | |
| IAASFCNTVQQLYVC | 101 | P53985 | |
| CNAESQCLYNQTSRV | 5036 | Q99102 | |
| LLSNCQQLNCQYKCT | 116 | Q9NZR2 | |
| LQFQVTNYCVRVCAT | 591 | Q8IV33 | |
| IANARVQNCAIIYCN | 31 | Q9NS40 | |
| NTKNSQPQCIVCVNY | 326 | Q16665 | |
| QTVIYQASQALNCCV | 731 | Q9NQW6 | |
| QVICGQNCTFVIQAN | 4031 | Q15751 | |
| IANARVENCAVIYCN | 31 | Q12809 | |
| NYNTCTTCRLQVCNL | 481 | Q9UPA5 | |
| CASLQAYAALCAQQN | 4731 | Q02817 | |
| GCLYQTCQQNQFTCQ | 3026 | P98164 | |
| NYEIRIQCCETVNVC | 2036 | P98088 | |
| SSTCVVDQTNNAYCV | 176 | P19883 | |
| VDQTNNAYCVTCNRI | 181 | P19883 | |
| KYQTLNCSVNVNCVN | 961 | P23229 | |
| ISQYATICQQLQAEV | 366 | Q86Y91 | |
| YRIQCCTSTVNQAQV | 146 | Q9Y2Y8 | |
| VDGNVSTIYCQNLCL | 581 | Q92794 | |
| QYEILCVSQFTLQCV | 71 | Q8TEA8 | |
| NNVLIQYTNACVKVC | 566 | O00471 | |
| YAAQCIAKLLQQCTT | 896 | O14981 | |
| TIECCRTNLCNQYLQ | 121 | P36894 | |
| LQIQCYQCEEFQLNN | 21 | Q8N2G4 | |
| SLCNAINVYNLTCNN | 986 | Q9BY12 | |
| INVYNLTCNNCSENC | 991 | Q9BY12 | |
| NTTLNVYLCQSENSC | 376 | Q8TDX9 | |
| QLIQEFCQEYLNQCC | 291 | Q08AD1 | |
| VYQCNSLEQAQAICK | 171 | O14713 | |
| QQCYNILGSFICQCN | 266 | Q12805 | |
| ICNVCSCVSVENVLY | 26 | Q8IW52 | |
| SVENIQSPCCSQAIY | 171 | Q9BWX1 | |
| RVYQCNICSKIFQNS | 736 | P57071 | |
| CKVIFSNQTNVVCQT | 971 | P08F94 | |
| YECQNGAQCIVVQQE | 1126 | O75094 | |
| CCYVFSAQQLQAAQV | 561 | Q9HC29 | |
| NVSSFQQAYITCLCS | 246 | Q13129 | |
| VCQSETCQRYLQAAI | 76 | Q7Z6I5 | |
| VQESQYQCLECGQLL | 71 | Q6ZN55 | |
| LVNFGNTCYCNSVLQ | 41 | O75317 | |
| FNEAQCNTAYQCLLI | 1791 | Q12888 | |
| VVINFQAYCCILQDC | 2996 | Q86WI1 | |
| ECYNGLNQCLTTTQN | 96 | Q9P255 | |
| EVQKVCNICVLYQTS | 456 | Q7Z3V4 | |
| LQNYQFTNSEVTCQC | 191 | O43592 | |
| YCKLCNVTLNSAQQA | 71 | Q9HA38 | |
| SQTLQSQRQYACELC | 386 | Q6ZSB9 | |
| NCNVVVQARLCVYNY | 981 | Q6ZMP0 | |
| VAETACNFQLTQYQI | 11 | Q8N8C0 | |
| QVQCNSCKTSAIPQY | 576 | Q5VZL5 | |
| NCSTCQNTACIIYSV | 461 | A6NMK8 | |
| LQCAACQQALTTSCY | 81 | O60663 | |
| ASYQVSIPQSCEQCL | 1636 | Q13459 |